Remarkably, we observed higher expression of PGC-1a in tumor samples from non-responders (Progressive Disease (PD)/ Stable Disease (SD)) than responders ((Complete Response (CR)/ Partial Response (PR)) (Figure 3G-H, Figure S3G). This evidence concerns the gene PPARGC1A and neoplasm.